Nematode modulation of inflammatory bowel disease by Rose A. K. Whelan et al.
REVIEW ARTICLE
Nematode modulation of inflammatory bowel disease
Rose A. K. Whelan & Susanne Hartmann &
Sebastian Rausch
Received: 6 October 2011 /Accepted: 11 October 2011 /Published online: 17 November 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract Inflammatory bowel disease (IBD) is a chron-
ic disease arising due to a culmination of genetic,
environmental, and lifestyle-associated factors and
resulting in an excessive pro-inflammatory response to
bacterial populations in the gastrointestinal tract. The
prevalence of IBD in developing nations is relatively
low, and it has been proposed that this is directly
correlated with a high incidence of helminth infections
in these areas. Gastrointestinal nematodes are the most
prevalent parasitic worms, and they efficiently modulate
the immune system of their hosts in order to establish
chronic infections. Thus, they may be capable of
suppressing unrelated inflammation in disorders such
as IBD. This review describes how nematodes, or their
products, suppress innate and adaptive pro-inflammatory
immune responses and how the mechanisms involved in
the induction of anti-nematode responses regulate colitis
in experimental models and clinical trials with IBD
patients. We also discuss how refinement of nematode-
derived therapies should ultimately result in the devel-
opment of potent new therapeutics of clinical inflam-
matory disorders.
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Abbreviations
AAM Alternatively activated macrophage
CD Crohn’s disease
DC Dendritic cell
DSS Dextran sodium sulfate
DNBS Dinitrobenzene sulfonic acid
IBD Inflammatory bowel disease
IFN Interferon
ES Excretory/secretory
Foxp3 Forkhead box P3
IL Interleukin
mLN Mesenteric lymph node
MPO Myeloperoxidase
RELM Resistin-like molecule
TGF Transforming growth factor
Th T helper cell
TLR Toll-like receptor
TNBS Trinitrobenzenesulfonic acid
TNF Tumor necrosis factor
Treg Regulatory T cell
TSLP Thymic stromal lymphopoietin
UC Ulcerative colitis
Introduction
Inflammatory bowel disease (IBD) is a chronic inflamma-
tory disorder that manifests in a dysregulated mucosal
immune response against intestinal bacteria. Human IBD
can be classified into two main characteristic forms:
ulcerative colitis (UC) and Crohn’s disease (CD). UC
generally involves T helper cell type 2 (Th2) and Th17-
driven inflammation, leading to superficial ulceration of the
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colon. CD is characterized by Th1-type-driven inflamma-
tion that leads to isolated, often transmural lesions and may
involve the entire gastrointestinal tract (Xavier and Podol-
sky 2007). IBD patients show relapsing and remitting
disease that is often lifelong.
The pathogenesis of IBD still remains incompletely
understood, but the complex etiology involves multiple
genetic, immunological, and environmental factors. The
intestinal microbiota is central for the initiation of IBD
development. Pathogenic or commensal bacteria trigger
microbial sensing systems, which initiate pro-inflammatory
responses by innate cells, such as dendritic cells and
macrophages producing interleukin (IL)-12/23, tumor ne-
crosis factor alpha (TNF-α), IL-6, IL-1β, reactive oxygen
species, and nitric oxide which leads to disrupted epithelial
barrier function in susceptible individuals. The following
activation of the adaptive immune system leads to the
strong production of inflammatory cytokines (interferon
gamma (IFN-γ), TNF-α, and IL-17A) by T helper (Th)
cells, which constitute the dominant force driving chronic
inflammation in IBD patients (Xavier and Podolsky 2007).
Genetic inheritance is a strong component of IBD devel-
opment; roughly 100 gene loci are currently linked to IBD
susceptibility (Anderson et al. 2011), and up to a 20-fold
increased risk of developing CD has been reported if a first-
degree relative is already afflicted. Predisposing polymor-
phisms linked to IBD development have been found in
genes commonly associated with immune reactions to the
intestinal flora and gut homeostasis. IBD-associated poly-
morphisms affect pro-inflammatory and regulatory cyto-
kines (e.g., TNF, IFNG, and IL10), their receptors (e.g.,
IL23R and IL1R2) as well as signaling pathways (e.g.,
SMAD3) and antigen presentation molecules or epithelial
innate defense factors (van Heel et al. 2002; Anderson et al.
2011; Duerr et al. 2006; Franke et al. 2010). Finally,
lifestyle-associated factors like diets rich in fat and animal
protein as well as smoking increase the risk of developing
IBD (Hou et al. 2011).
The prevalence of IBD, allergies, and autoimmune
disorders is increased in industrialized nations in
comparison to developing countries. This correlation
has been explained by the so-called “hygiene hypothe-
sis,” which suggests that the decreased exposure to
previously common infections that have subsequently
been reduced as a result of increased hygiene in the
western world may result in increased incidence of
autoimmune and inflammatory disorders (Strachan
1989). In line with this concept, parasitic worm infections
are efficiently controlled by antihelminthic drugs and
hygiene practices in developed countries, and their
eradication coincides with an increase in the development
of immune disorders, including IBD (Elliott et al. 2000).
The vertebrate immune system has coevolved under
constant attack from parasitic helminths, leading to a
balance between host protective inflammatory mecha-
nisms controlling worm infections and immune modula-
tion conducted by the parasites (Fumagalli et al. 2009;
Maizels et al. 2004). The immune system of individuals
living in an environment lacking these parasites may be
insufficiently trained and modified and thus develop
aberrant immune reactions to common antigens or com-
mensal bacteria. Experimental infections with helminths
or treatment with immunomodulatory worm-derived com-
ponents has shown that helminths can efficiently suppress
unrelated immune reactivity, including colitis. While
current anti-inflammatory and immunosuppressive IBD
therapies may induce and maintain remission, not all
patients respond to such therapies and no long-term
curative drug therapy has been developed to date. Thus,
studies in mouse models and human trials with IBD
patients showing preventive and therapeutic effects of
helminths have generated substantial interest. For the
purpose of this review, we will focus on anti-colitic
effects of gastrointestinal nematodes, a diverse phylum
with a large body of research regarding modulation of the
host’s immune response.
Immune modulation by nematodes: the diverse targets
The induction of highly skewed T helper cell type 2 (Th2)
responses to nematodes is associated with the efficient
control of worm infections (see Table 1). However,
nematodes have coevolved efficient immune evasion
mechanisms enabling their prolonged survival and repro-
duction in the host (see Fig. 1). The modulation of the
immune response is seen as an evolutionary adaptation that
is also beneficial for the host as overt immunopathology
and thereby damage to the host is avoided (Maizels et al.
2004). Nematode-induced immune modulation also has the
ability to suppress bystander responses to unrelated
antigens, and nematode infections have also been shown
to suppress unrelated inflammation such as airway hyper-
reactivity (Hartmann et al. 2009; Kitagaki et al. 2006;
Wilson et al. 2005). It is unlikely that the potent
suppression of such inflammatory processes is the conse-
quence of one dominant modulation pathway, but rather
results from the interference with multiple steps of elicited
immune responses.
Indeed, live nematodes and their excretory/secretory
(ES) products have been shown to modulate a plethora of
innate and adaptive immune cells (see Fig. 1). Nematode
infections enhance the induction of dendritic cells (DCs)
supporting the outgrowth of regulatory T cell populations
and production of anti-inflammatory IL-10 in the intestine
and gut-draining lymph nodes (Li et al. 2011). Macro-
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phages are a target of nematode modulation, acquiring a
regulatory phenotype (Klotz et al. 2011; Schnoeller et al.
2008; Siracusa et al. 2008). T cell responses are suppressed
in models of chronic nematode infections (Hartmann et al.
Table 1 Overview of murine nematode infection models applied in the context of IBD
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Fig. 1 A schematic overview of mechanisms suppressive to IBD
conducted by intestinal nematodes. In susceptible individuals, envi-
ronmental factors or genetic predisposition provokes damage to the
epithelial barrier of the intestine and lead to a mucosal immune
response, with macrophages producing high amounts of pro-
inflammatory cytokines (TNF-α and others) and tissue-destructive
effector molecules (NO, ROS). The lost integrity of the epithelial cell
barrier and insufficient mucus layer facilitate bacterial translocation to
subepithelial regions. DCs are activated after recognition of bacterial
components and migrate to the gut-draining mLN, where they prime
naïve T cells and produce IL-12/23, leading to CD4+ T cell
differentiation into Th1 and Th17 cells. These migrate to the intestine
and perpetuate the inflammatory response, e.g., via IFN-γ production
which supports the activation of macrophages. On the contrary, DC
activated via molecules released from nematodes will prime Th2 cells
producing IL-4/-13. Tissue-derived cytokines like TSLP and IL-25
support the development of the Th2 response and suppress pro-
inflammatory responses by DC and macrophages. The Th2 response
counterbalances the activation and outgrowth on the opposing Th
populations. IL-4/13 leads to the development of macrophages with an
alternatively activated phenotype (AAM) expressing factors like
arginase and RELM-α needed for wound repair. IL-4/13 also leads
to an increased turnover of epithelial cells, hyperplasia of goblet cells,
and increased mucus production. IL-22-producing Th cells may
increase epithelial integrity. ES products from the nematodes directly
modulate DC, suppressing their expression of MHCII, costimulatory
molecules, and production of Th1- and Th17-supportive cytokines
(see inlay). Certain nematode species directly favor the induction of
Foxp3+ regulatory T cells via secretion of a mimic to TGF-β. DCs
with a tolerogenic phenotype (e.g., production of IL-10) accumulate in
mLN and support the production of IL-10 by T cells and the
outgrowth of Treg populations. Tregs limit the activation and effector
function of Th1 and Th17 as well as Th2 cells. AAM alternatively
activated macrophage, CAM classically activated macrophage, DC
dendritic cell, EC epithelial cell, E/S excretory/secretory components,
IFN-γ interferon-γ, IL interleukin, mLN gut-draining mesenteric
lymph nodes, NO nitric oxide, RELM-α resistin-like molecule-α,
ROS reactive oxygen species, TGF-β transforming growth factor-β,
Th helper T cell, TNF-α tumor necrosis factor-α, Treg regulatory T
cell, TSLP thymic stromal lymphopoietin
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1997; Metwali et al. 2006) as well as in human patients
with long-lasting or recurring infections (Doetze et al. 2000;
Fujiwara et al. 2009). The latter is seen as a consequence of
limited activation by innate cells and increased numbers and
activation of regulatory T cell (Treg) subsets, such as
forkhead box P3 (Foxp3+) expressing natural Tregs and
induced Treg populations specialized for the expression of
the anti-inflammatory cytokines transforming growth factor
beta (TGF-β) (Th3 cells) and IL-10 (Tr1 cells) (Chaudhry et
al. 2011; Doetze et al. 2000; Metenou et al. 2010). The
understanding of how nematodes afflict the different immune
cells of their hosts may help to specifically interfere with
inflammatory disorders such as IBD.
The largest body of evidence for a preventive and
curative effect of nematodes on gastrointestinal inflam-
mation comes from commonly used murine colitis and
nematode infections models (see Box 1, Tables 1 and
2). In the following section, we will focus on how
nematode infections or nematode components modulate
the multiple layers of immune responses and how this is
connected to the control of inflammatory disorders of the
gut.
Skewing the system: Th2-related protection against IBD
A highly conserved feature of nematode infections is the
polarization towards a Th2 response and counter-regulation
of Th1 responses (see Fig. 1). Thus, many studies have
aimed to dissect how the nematode-induced Th2 response
antagonizes pathological Th1 and Th17 responses in
murine models of colitis.
Infections with Heligmosomoides polygyrus have potent
protective effects and suppress inflammation in several
models of IBD (see Table 2). Amelioration of trinitrobenze-
nesulfonic acid (TNBS)-induced or piroxicam-triggered
colitis in IL-10−/− mice (see Box 1) by prior infection with
H. polygyrus coincided with increased colonic levels of Th2
cytokines, while local IL-12, IFN-γ, and TNF-α were
conversely suppressed, suggesting that the preventive effect
was largely due to the nematode-induced Th2 response
counterbalancing Th1-driven tissue damage (Elliott et al.
2004; Setiawan et al. 2007; Sutton et al. 2008). Suppression
of Th17-driven colitis by H. polygyrus in the IL10−/− model
has been linked to IL-4, a key Th2 cytokine. In vitro
blockade of IL-4 restored the IL-17A production by T cells
Box 1: Mouse colitis models studied for nematode immunomodulation 
DNBS/TNBS model 
Induction: Immunological mediated model induced by the haptens di- or trinitrobenzene sulfonic acid (DNBS, TNBS) and the intestinal 
microbiota. Intrarectal application of chemicals in ethanol leads to disruption of epithelial layer (Scheiffele and Fuss 2002). Initiator of 
inflammatory response: IL-12/23 production by DC and macrophages, TNF- /IL-1 /IL-6/IL-18 from macrophages (Guan et al. 2011; 
Neurath et al. 2000; Scheiffele and Fuss 2002). Dependent on adaptive immunity: Th1/17 cells drive the colitic response. Not working in T 
cell deficient mice (Scheiffele and Fuss 2002; Guan et al. 2011). Interference with inflammation: Blockade of IL-12/23 TNF-  (Neurath et 
al. 2000, Guan, 2011 #124) Relevance to human IBD: Transmural inflammatory lesions share similarity with CD. Long lasting (about 8-12 
weeks in susceptible mice). Responds to current treatments of IBD (sulfasalazine, gluocorticoids, cyclosporine, anti-TNF-  antibodies).
DSS model 
Induction: feeding of dextran sodium sulphate (DSS) in drinking water leads to disruption of colonic mucosals barrier. DSS is directly toxic 
to epithelial cells and allows translocation of intestinal bacteria driving the pro-inflammatory response. Does not work in germ-free mice. 
Initiator of inflammatory response: macrophages sensing intestinal bacteria (Dieleman et al. 1994). Dependent on adaptive immunity:
Macrophage-driven inflammation also detected in T cell deficient mice. Repetitive cycles of DSS application lead to exacerbated 
inflammation driven by Th1, Th17 and Th2 cells (Hall et al. 2011). Interference with inflammation: Removal of microbiota by antibiotic 
treatment; blockade of IL-12/23, TNF- . Relevance to human IBD: Early recruitment of DC, macrophages and neutrophils reflects findings 
in human IBD patients (Hall et al. 2011). Repetitive DSS mimic relapse and remission phases.  
IL-10-/- Model
Induction: develops spontaneously in IL-10-/- mice or after transfer of IL-10-/- T cells into RAG-/- mice deficient in mature T cells. 
Piroxicam treatment needed for synchronized colitic response. Does not work in germ-free mice (Blum et al. 2004; Kuhn et al. 1993). 
Initiator of inflammatory response: increased IL-12/23 production in response to bacterial stimuli due to increased mucosal permeability 
and lack of regulatory IL-10 circuits. Overt activation of Th1/17 effector cells liberated from (Tr1/Treg?) regulation (Elliott et al. 2004). 
Dependent on adaptive immunity: Unregulated pro-inflammatory T effector responses is responsible for colitis development. Interference 
with inflammation: removal of microbiota by antibiotic treatment; blockade of IL-12; co-transfer of Treg. Relevance to human IBD:
Model for transmural inflammation as also seen in CD patients. Reflects unregulated T cell responses due to a defect in regulatory circuits 
that may be involved in genetically predisposed IBD patients.  
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from nematode-infected IL10−/− mice. Conversely, addition
of IL-4 (and more so the combination of IL-4 and IL-10)
blocked IL-17A secretion by T cells from colitic IL-10−/−
mice, showing that nematode-driven Th2 effector cytokines
effectively suppress pro-inflammatory responses (Elliott et
al. 2008). Importantly, H. polygyrus infection not only
prevented development of colitis when given to mice before
administration of the colitis trigger piroxicam, but was also
able to control established colitis in IL-10−/− mice (Elliott et
al. 2008).
A recent publication specifically addressed the role of
IL-13, a Th2 cytokine sharing many features with IL-4, and
IL-13Rα2, the soluble IL-13 decoy receptor limiting the
levels of bioactive IL-13 in the body, in Trichuris muris
infection (Wilson et al. 2011). Infections with T. muris lead
to a pathological response resembling colitis in IL-10−/−
mice, which were found to express high levels of IL-13Rα2
following T. muris infection or piroxicam treatment. Using
IL-10/IL-13Rα2 double knockout mice, the authors found
that in the absence of the decoy receptor a subsequent
increase in IL-13 bioactivity protected against IFN-γ and
IL-17A-mediated colitis. An increase in IL-13 and de-
creased IFN-γ were also reported in Trichinella spiralis-
mediated amelioration of dinitrobenzene sulfonic acid
(DNBS) colitis (Khan et al. 2002). Taken together, these
data suggest that the initial strong induction of Th2
responses by nematode infections counterbalances the
development of colitogenic Th1 and Th17 responses and
show that even fully developed colitis may be controlled by
nematode treatment.
The first line of modulation: intestinal epithelial cells
and tissue-derived cytokines
The integrity of the epithelial layer is of pivotal importance
for the prevention of inappropriate inflammatory responses
against the commensal gut microbiota (Saenz et al. 2008).
Intestinal nematode infections lead to a rapid innate
response that results in a bias towards the induction of an
adaptive Th2 response in order to expel developing larvae
or adults. Recent work has shown how the epithelial-
derived cytokines thymic stromal lymphopoietin (TSLP),
IL-25, and IL-33 influence innate and adaptive responses at
mucosal sites and how they are involved in promoting Th2
responses to intestinal nematode infections (Saenz et al.
2008; Humphreys et al. 2008; Price et al. 2010; Taylor et al.
2009). TSLP and IL-25 have been shown to turn off the
expression of IL-12/23 p40 by DCs and thus impair their
ability to drive Th1 responses (Massacand et al. 2009;
Taylor et al. 2009). In the absence of TSLP, T. muris
infection led to severe gut pathology coinciding with
increased Th1 and Th17 responses (Taylor et al. 2009).
Importantly, the same study showed that mice deficient in
TSLP develop a more severe pathology in response to
dextran sodium sulfate (DSS; see Box 1) treatment in the
chemically induced colitis model. Biopsies from patients
with active CD showed a lack of TSLP expression
compared to healthy controls (Rimoldi et al. 2005).
Treatment of colonic macrophages from IBD patients with
the tissue-derived cytokine IL-25 restrained their synthesis
of IL-12/23 and, similar to TSLP, patients with active UC
or CD produced less IL-25 than healthy controls. Further-
more, application of IL-25 ameliorated experimental colitis
in mice (Caruso et al. 2009). IL-33, on the other hand, is
discussed as a factor driving gut inflammation, especially in
Th2-related UC (Seidelin et al. 2011) and was shown to
exacerbate DSS-induced experimental colitis (Imaeda et al.
2011).
Another innate effector molecule produced by the
intestinal epithelium, namely goblet cells, in response to
worm infections is resistin-like molecule beta (RELM-β).
RELM-β is induced by IL-4/-13 produced by early innate
sources and Th2 cells and is directly involved in host
defense against intestinal nematodes by binding to the
chemosensory apparatus of the worms (Artis et al. 2004;
Herbert et al. 2009). Furthermore, it increases mucin
secretion by goblet cells and ameliorates TNBS colitis in
mice by strengthening the mucus layer needed for gut
barrier function and immune homeostasis (Hogan et al.
2006; Krimi et al. 2008).
The early induction of TSLP and IL-25 by nematode
infections permits the development of adequate mucosal
Th2 responses directed against the parasite while suppress-
ing pathogenic Th1 and Th17 responses. Thus, the
increased expression of tissue-derived factors like TSLP,
IL-25, and RELM-β induced by nematodes seems integral
to a protective role of these parasites in colitis models.
While many studies focus on these tissue-derived cytokines
as targets in modulating Th2-related atopic disorders,
nematode infection models may reveal how these early
players in mucosal immune responses might also be targets
for suppressing Th1- and Th17-related gut inflammation.
DC as nematode modulation targets
Dendritic cells (DCs) are the most potent antigen-
presenting cells and critical inducers of adaptive immunity.
They play a decisive role in directing the differentiation of
distinct Th cell as well as T regulatory cell subsets in
response to pathogens (MacDonald and Maizels 2008). In
active lesions of IBD patients, increased numbers of
activated DCs are detectable, expressing toll-like receptors
(TLRs) essential for the recognition of microbial pathogens
and commensal bacteria as well as co-stimulatory mole-
cules needed for the activation of T cells. As to be expected,
they also produce high levels of inflammatory cytokines,
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including IL-12/23p40 (Niess 2008). Given the fact that the
production of IL-12/23 by gut-associated DCs is essentially
involved in the induction of colitogenic Th1 and Th17
responses, it is interesting to note that many in vitro and in
vivo studies show that nematode infections as well as
nematode products efficiently shut down the ability of DCs
to produce these pro-inflammatory factors.
Treatment of DCs with ES products of parasitic
nematodes selectively suppresses their production of IL-12
in response to TLR ligation by bacterial components and/or
the expression of co-stimulatory molecules (such as CD80/
86 and CD40) and antigen presentation molecule MHCII
(Balic et al. 2009; Li et al. 2011; Segura et al. 2007).
Similarly, blood monocyte-derived DCs from patients
infected with the hookworm Necator americanus were
impaired in their ability to induce T cell activation and
proliferation (Fujiwara et al. 2009). For T. muris, it was
shown that infection led to a rapid increase of immature
DCs in the lamina propria of the large intestine (Cruick-
shank et al. 2009). The colonic DCs were shown to extend
dendrites between adjacent epithelial cells into the gut
lumen (Cruickshank et al. 2009). Therefore, it is conceiv-
able that DCs are a direct target of immunomodulatory
components secreted by T. muris and other intestinal
nematodes and may be modulated directly in the intestine.
Divergent DC populations with pro-tolerogenic properties
have been characterized, like mucosal RALDH+CD103+ DCs
or lymphoid CD205+ DCs driving the induction of regula-
tory T cells and plasmacytoid DCs inducing IL-10 produc-
tion by T cells (Coombes and Maloy 2007; Pulendran et al.
2010; Yamazaki et al. 2008). This raised the question
whether nematodes might support such pro-tolerogenic DC
populations and thus prevent the development of patholog-
ical T cell responses in the gut. A recent study provides first
evidence for prevention of colitis by efficient modulation of
DCs and other innate immune cells by an intestinal
nematode. In the IL-10−/− T cell transfer colitis model, a
transient infection with H. polygyrus weeks before the
IL-10−/− T cell transfer led to protection from colitis by
suppressing the subsequent generation of colitogenic Th1
and Th17 effector cells. Changes in the composition of
lamina propria-derived DCs populations were related to
the inhibition of colitis as DCs showed decreased
expression of co-stimulatory molecules and IL-12/23 p40
and contained higher frequencies of plasmacytoid-like
DCs known to exert a regulatory function in disease
models (Hang et al. 2010).
A refined analysis of intestinal nematode-induced
changes in DC populations has been carried out in the
group of Rick Maizels using H. polygyrus and Nippos-
trongylus brasiliensis as models for chronic and acute
nematode infections. In both infections, the number of DCs
expressing high levels of co-stimulatory molecules dropped
dramatically in gut-draining mesenteric lymph nodes
(mLN), a finding even more prevalent during chronic H.
polygyrus infection (Balic et al. 2009). This coincided with
an increased Th2-inducing and restrained Th1-priming
capacity of mLN DCs (Balic et al. 2009). In a subsequent
study, an increased frequency of DCs with a pro-tolerogenic
phenotype distinct from previously described CD205+,
CD103+, and plasmacytoid DCs was detected in the mLN
of H. polygyrus-infected mice (Smith et al. 2011). These
DCs responded poorly to TLR ligands and had a low
efficiency in driving Th1 and Th17 differentiation, but were
superior in driving Th2 responses and de novo induction of
Foxp3+ Tregs (Smith et al. 2011).
It is thus conceivable that the reduction in pro-
pathogenic DCs and the increase of pro-tolerogenic DCs
found during nematode infections are largely contributing
to the profound anti-inflammatory effects of these parasites
seen in IBD models and clinical trials. The fact that
intestinal DCs sample antigen directly from the gut lumen
(Niess et al. 2005) makes them a potential target for direct
modulation via ES products of nematodes. Thus, it is also
conceivable that immature DCs attracted to nematode-
infected intestinal sites are efficiently modulated by ES
products of the parasites, either blocking their further
maturation, inhibiting migration to lymphoid sites, or
equipping them with pro-tolerogenic functions exerted after
their arrival at sites of T cell priming.
It should also be noted that the mechanisms involved in
immune modulation may vary between species of nematodes.
For example, the suppression of IL-12/23 p40 expression by
DCs is dependent on the tissue-derived cytokine TSLP in T.
muris infection, while H. polygyrus and N. brasiliensis are
able to bypass the need for TSLP, directly suppressing the
expression of pro-inflammatory cytokines by DCs through
ES components (Massacand et al. 2009). Therefore, for
developing nematode-derived anti-colitic therapies, differ-
ences between immune response induced between nematode
species must be considered.
Nematode modulation of macrophages
Intestinal macrophages are known for their contribution to
IBD as effector cells driving pathology by release of the
pro-inflammatory cytokines TNF-α, IL-1β, IL-6, IL-12,
and IL-23, reactive oxygen species, and nitric oxide (Qualls
et al. 2006; Bar-On et al. 2011). On the other hand, they are
necessary for maintenance of intestinal homeostasis via
induction of Treg differentiation (Denning et al. 2007).
During nematode infections, macrophages acquire a special
phenotype (named alternatively activated macrophages;
AAMs) in response to the Th2 cytokines IL-4 and -13
(Loke et al. 2007; Reece et al. 2008; Siracusa et al. 2008;
Gordon 2003). They are characterized by the expression of
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arginase-1, RELM-α, and YM-1, effector molecules in-
volved in wound healing and protection against nematodes
(Kreider et al. 2007). Importantly, AAMs express low
levels of pro-inflammatory cytokines.
While not yet studied directly in nematode infections,
AAMs may play a role in amelioration of gastrointestinal
inflammation as AAMs are found in higher amounts in
human patients with inactive CD compared to those with
active disease (Hunter et al. 2010). This finding along with
the observation that nematode infections induce AAMs
with wound healing and tissue remodeling properties, as
well as potential T cell suppressive capabilities, (Mylonas et
al. 2009; Siracusa et al. 2008) prompts the question whether
AAMs might be involved in colitis prevention in nematode
infection models.
Recent in vivo and in vitro data support this view:
AAMs isolated ex vivo have the potential to ameliorate
DSS-induced colitis after transfer (Weisser et al. 2011), and
AAMs elicited by in vivo application of the Th2-associated
tissue-derived cytokine IL-25 conferred protection against
TNBS-induced colitis in an IL-4-, IL-13-, and TGF-β-
independent manner (Rizzo et al. 2011). Helminth-derived
AAMs are also found to have anti-inflammatory effects and
are involved in wound healing (Loke et al. 2007). In a
murine wound healing model, AAMs elicited by the filarial
nematode Brugia malayi were found to be recruited to the
site of injury after sham surgery of the intestine (Loke et al.
2007). In models with intestinal barrier disruption, as in the
DSS model of colitis, it is easy to speculate that wound
healing by AAMs induced during nematode infection could
participate in the protective effect observed. AAMs gener-
ated in vitro reduced colonic inflammation in DNBS-treated
mice, and similarly, a protective, anti-colitic effect mediated
by tapeworm infections was reverted when intestinal
macrophages were depleted (Hunter et al. 2010). Interest-
ingly, the same study showed that patients with active
colitis had reduced numbers of AAMs in intestinal biopsies,
while inactive CD correlated with increased numbers of
intestinal AAMs (Hunter et al. 2010). The observation that
remission in CD patients is correlated with an accumulation
of AAMs in the intestine coupled with the reported
protective role of helminth-induced AAMs in murine
models of colitis suggests that a better understanding of
the role of AAMs may yield important information for the
application of modulated macrophage subsets as therapy for
intestinal inflammatory disorders.
Anti-inflammatory cytokines: nematodes supporting
the production of IL-10 and TGF-β
IL-10 and TGF-β are canonical regulatory cytokines which
are produced by a multitude of innate and adaptive immune
cells as well as epithelial cells. Both play a crucial role in
maintaining immune homeostasis of the gut. They suppress
the production of pro-inflammatory cytokines by innate
cells and the development of Th1 cells (Doligalska et al.
2006; Elliott et al. 2008; Ince et al. 2009) while supporting
and inducing regulatory T cell subsets (Coombes and
Maloy 2007; Murai et al. 2009). Genetically modified mice
with dysfunctional TGF-β signaling (Fahlen et al. 2005;
Gorelik and Flavell 2000) or lacking IL-10 expression
(Asseman et al. 1999; Murai et al. 2009) succumb to severe
colitis due to a dysregulated cytokine milieu with overt pro-
inflammatory T cell activation. Tregs are one important
source of both cytokines (Monteleone et al. 2008; Rubtsov
et al. 2008), and IL-10 from intestinal macrophages has
been shown to induce Foxp3+ Tregs in conjunction with
retinoic acid and exogenous TGF-β (Denning et al. 2007).
Macrophage-derived IL-10 also maintains Foxp3 expres-
sion in gut Tregs in the inflamed intestine (Murai et al.
2009).
Nematode infections provoke the production of IL-10
and TGF-β by T cells (indicative of a Treg phenoytpe, see
next section) (Doetze et al. 2000; Finney et al. 2007;
Rausch et al. 2008; Rausch et al. 2009; Satoguina et al.
2002; Schopf et al. 2005), and both cytokines restrain
protective antiparasitic immune responses and immunopa-
thology (Grainger et al. 2010; Specht et al. 2004). Thus, IL-
10 and TGF-β are central mediators of nematode-induced
protection against intestinal inflammation. H. polygyrus
infection leads to an increased production of IL-10 by
CD4+ T cells in the lamina propria of the lower intestine
while decreasing levels of IFN-γ and IL12/23 p40
(Setiawan et al. 2007). In the TNBS model, IL-10 was
proposed to be essential for disease resolution by H.
polygyrus because blockade of the IL-10R restored Th1
responses and reversed the protection against colitis
(Setiawan et al. 2007). More recently, the importance of
TGF-β was shown in H. polygyrus-mediated suppression
of intestinal inflammation (Ince et al. 2009). Control of
Th1-driven colitis by H. polygyrus required intact TGF-β
signaling as mice with a defective form of TGF-βRII
showed no reduction in intestinal Th1 cytokine production
and were not protected from colitis by H. polygyrus
infection. Interestingly, this study indicated a link between
TGF-β and IL-10 expression as TGF-βRII-defective mice
lacked the increased intestinal IL-10 levels seen in H.
polygyrus-infected wild-type mice. H. polygyrus also
modulates the response of T cells to bacterial compo-
nents in favor of an anti-inflammatory cytokine re-
sponse. During infection, intestinal mucosal T cells were
found to start expressing TLR-4, the receptor for
bacterial lipopolysaccharide (LPS). Both CD4+ and
CD8+ intestinal T cells from H. polygyrus-infected mice
reacted with increased production of TGF-β in response to
LPS stimulation (Ince et al. 2006). This mechanism may
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help to maintain the mucosal integrity during intestinal
worm infections and may be involved in suppressing
colitic responses by nematodes.
There is increasing evidence that IL-10 from nematode-
modulated DCs or T cells primed by these DCs might be
important for nematode-mediated protection against colitis.
DCs treated with ES products of H. polygyrus or the
hookworm Ancylostoma caninum gained the ability to
induce IL-10 in primed T cells (Cuellar et al. 2009; Segura
et al. 2007). H. polygyrus infection led to an increase in IL-
10-expressing DCs in mLN that supported the induction of
Tregs and IL-10 production by T cells (Balic et al. 2009; Li
et al. 2011).
Resident gut macrophages also serve as a source for IL-
10 and TGF-β in the intestine (Gordon 2003; Murai et al.
2009), and intestinal macrophages can confer protection
from T cell transfer colitis in an IL-10-dependent manner
(Murai et al. 2009). It is thus tempting to speculate that
nematodes might support the inherent competence for IL-10
production in resident intestinal macrophages and, at the
same time, prevent damage resulting from the release of
high levels of inflammatory mediators by monocytes/
macrophages migrating to the gut tissue during onset or
relapse of IBD. It remains to be elucidated whether this
might be a mechanism centrally involved in the nematode-
mediated blockade of colitis in diverse gut inflammation
models.
Treg induction and activation by nematodes
Regulatory T cells (Tregs) are essential for the control of
immune disorders, and their role in preventing spontaneous
or induced gut inflammation has been extensively studied
(Campbell and Koch 2011; Izcue et al. 2009). Mice lacking
the Treg-associated lineage transcription factor Foxp3 are
prone to develop fatal colitis due to a dysregulated cytokine
milieu with overt pro-inflammatory T cell activation. The
production of TGF-β and IL-10 by Tregs suppresses
inflammation driven by effector T cells and innate cells
(Chaudhry et al. 2011; Liu et al. 2006), and both cytokines
are important for Treg maintenance in what appears to be a
positive feedback loop (Murai et al. 2009; Fantini et al.
2004; Mucida et al. 2007).
Increased frequencies of Tregs are detected in nematode-
infected mice (D’Elia et al. 2009; Finney et al. 2007;
Grainger et al. 2010; McSorley et al. 2008; Rausch et al.
2008) and humans (Babu et al. 2006; Matera et al. 2008;
Metenou et al. 2010; Montes et al. 2009). Our group, as
well as others, has shown that H. polygyrus-infected mice
have higher frequencies of CD4+ Tregs and that they are
stronger suppressors than Tregs from naïve controls
(Finney et al. 2007; Rausch et al. 2008; Rausch et al.
2009). Infection-derived Tregs had an increased expression
of the αE(CD103)β7 integrin linked to an activated effector/
memory phenoytpe of Foxp3+ Tregs (Huehn et al. 2004).
CD103 binds to E-cadherin expressed on epithelial cells,
possibly enabling prolonged retention of these Tregs in the
intestine (Cepek et al. 1994). Most importantly, the
depletion of Tregs during infections with H. polygyrus
and T. muris increased intestinal pathology (D’Elia et al.
2009; Rausch et al. 2009). Thus, regulatory T cell
populations are one focus in nematode protection against
gut inflammation.
CD4+ T cells isolated from the intestines of H.
polygyrus-infected mice efficiently blocked IFN-γ pro-
duction of T cells derived from worm-free mice. Although
data on their Foxp3 expression are lacking, this shows the
induction of a regulatory phenoytpe in gut-derived CD4+
cells during H. polygyrus infection. The gut-derived CD4+
T cells produced large amounts of IL-10, coinciding with
the blockade of TNBS colitis in H. polygyrus-infected
mice. Blockade of IL-10 in vitro restored the suppressed
IFN-γ and IL-12/23 p40 production by lamina propria
cells derived from H. polygyrus-infected donors. In vivo,
IL-10 blockade worsened TNBS colitis in H. polygyrus-
infected mice (Setiawan et al. 2007). An earlier study
linked an increased Foxp3 expression in mLN cells of H.
polygyrus-infected mice to the protection from colitis
achieved by T cell transfer from infected to naive IL-10−/−
mice (Elliott et al. 2004). As transfer of IL-10−/− T cells
from H. polygyrus-infected donors blocked colitis in IL-
10−/− recipients, the suppression of intestinal inflammation
exerted by regulatory T cells activated by the worm
infection is not solely based on IL-10 production.
Interestingly, H. polygyrus also induces a CD8+ Treg
population. CD8+ T cells isolated from the intestines of H.
polygyrus-infected mice were able to largely inhibit
proliferation of spleen cells from naïve mice in vitro,
whereas T cells isolated from naïve mice showed very
little effect. The H. polygyrus-driven regulatory activity in
CD8+ intestinal T cells was independent of IL-10 and
TGF-β, but worked in a contact-dependent manner
(Metwali et al. 2006).
Recently, it was shown that ES products of H. polygyrus
(and the related nematode Teladorsagia circumcincta)
contain a functional mimic of TGF-β able to induce Foxp3
expression in CD4+ T cells in vitro, thus potentially
enhancing the suppressive natural Treg pool (Grainger et
al. 2010). Importantly, the study also shows that H.
polygyrus infection greatly enhanced the induction of Tregs
specific for an irrelevant antigen in a model of oral
tolerance induction. This shows that nematodes are able to
induce Tregs not specific for parasite antigen and suggests
that the induced Tregs may be of essential benefit in
regulating dyregulated immunity or bowel inflammation
driven by the microbiota.
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Taken together, it is clear that Tregs exposed to
nematodes or nematode antigens are highly activated and
may efficiently control immune responses. However, more
work is needed to elucidate the pathways involved in Treg
activity in intestinal nematode infections and their contri-
bution to the amelioration of colitis. In future studies, the
Treg populations essentially involved in amelioration of
colitis by nematode infections should be better character-
ized. It is not yet clear whether natural CD4+Foxp3+T cells,
induced TGF-β+ Th3, or IL-10+ Tr1 cells are predominant-
ly involved in suppressing colitis. The recently described
IL-35 producing induced Tregs found expanded in T. muris
infection (Collison et al. 2010) should also be evaluated as
possible anti-colitic players supported by worm infections.
Clinical trials and case studies
The experimental work in mouse models of colitis showed
that nematodes have potent immunomodulatory effects and
lead to the induction of regulatory pathways. This gener-
ated interest in adapting experimental helminth application
as a therapy in human disease. Clinical trials with IBD
patients treated with ova from the pig specific whipworm
Trichuris suis (see Table 3) showed an amelioration of
symptoms with a decreased disease activity in nematode-
treated patients (Summers et al. 2003; Summers et al.
2005). In the first T. suis study, small groups of ulcerative
colitis and Crohn’s disease patients were given 2,500 T. suis
ova orally, and no adverse effects were observed (Summers
et al. 2003). In three of four CD patients, remission was
achieved within 12 weeks of T. suis ova ingestion. Since T.
suis is not adjusted to the human host, it is considered as
incapable of maintaining a chronic infection, and it was
proposed that T. suis ova should be ingested every 3 weeks
after the initial dose in order to maintain remission of
colitis. In the second T. suis trial (Summers et al. 2005), 29
CD patients were treated with this regimen, and almost
80% responded, with 73% entering remission within
24 weeks of treatment. As immune reactivity was not
measured in blood or tissue biopsies from the patients, the
mechanism of T. suis-mediated amelioration of CD/UC
remains elusive.
A recent case study of an UC patient refractory to
standard treatment investigated the effects of Trichuris
trichiura, a close relative of T. suis infective for humans.
The patient entered complete remission for 3 years after
ingestion of two doses of embryonated T. trichiura eggs,
leading to chronic infection (Broadhurst et al. 2010).
Following a relapse phase, the patient ingested a third dose
of T. trichiura, again leading to improvement of histopath-
ological findings. The remission after reinfection correlated
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producing Th cells, while frequencies of Th cells producing
the pro-colitic cytokines IFN-γ, IL-17, and TNF-α
remained largely unchanged (Broadhurst et al. 2010). IL-
22, a cytokine produced by Th17 among other cells, is
known to support mucosal integrity by promoting wound
healing, increasing mucus production by goblet cells, and
proliferation of epithelial cells, thus increasing mucosal
barrier function (Eyerich et al. 2010). It was hypothesized
that the infection with T. trichiura led to the induction of
Th2- and IL-22-producing cells (in order to expel the
parasite infection) and that these effector cells synergize in
reducing intestinal pathology as a bystander effect by
increasing the mucosal integrity. Studies with more patients
are clearly needed to verify this hypothesis.
Refining and advancing nematode derived therapies
While infection with certain species of helminthes may
result in a beneficial suppression of dysregulated inflam-
mation, it is important to consider the consequences of
administering helminths to patients as they are pathogens
with the potential to induce adverse effects. High-dose
infections with hookworms (e.g., N. americanus) or the
whipworm T. trichiura can lead to a dysentery condition,
malnutrition, and anemia as well as decreased cognitive
function and retarded development in school-age children
(Bager et al. 2011; Croese et al. 2006; Stephenson et al.
2000). The Th2 and regulatory immune response elicited in
nematode infections may also have negative consequences
in terms of responses to bystander infections. Nematodes
blocking inflammatory Th1 response have been shown to
enhance the susceptibility of the host to gastrointestinal
bacterial pathogens (Chen et al. 2005; Chen et al. 2006),
tuberculosis (Potian et al. 2011), and plasmodium infection
(Tetsutani et al. 2009). Therefore, infections with live
nematodes adapted to humans are not the ideal option for
treatment of IBD.
As depicted above, eggs from T. suis—a species
maladjusted to the human host—have been used in clinical
trials to treat IBD as a way to circumvent the deleterious
effects of worm infection. While it is thought that T. suis
ova are unable to mature into breeding adults in the human,
a case study of a 16-year-old boy treated with T. suis ova
for IBD found not only an adult male worm in the intestinal
lumen of the boy but also suggested that the gastrointestinal
inflammation present was due to a T. suis-induced Th2
inflammatory response (Kradin et al. 2006). Likewise, in a
recent double-blind placebo trial, a significant increase in
the number of patients reporting gastrointestinal symptoms,
such as diarrhea and abdominal pain, was observed in T.
suis ova-treated patients compared to the placebo-
administered control group (Bager et al. 2011). The human
specific hookworm N. americanus has also been adminis-
tered in CD patients in an attempt to ameliorate disease
activity (Croese et al. 2006). While no significant decrease
in CD activity index was observed for 17 weeks, enterop-
athy was noted both in N. americanus-treated CD patients
and in human N. americanus reservoir donors (Croese et al.
2006). More recently, in a double-blind placebo control
study, infective N. americanus larvae were given to celiac
disease patients. An increase in nausea, bloating, and
itchiness at infective sites was observed in early coloniza-
tion periods lasting up to 16 weeks (Daveson et al. 2011).
At 20 weeks postinfection, patients began a 5-day gluten
challenge that resulted in no significant difference between
the placebo control and treatment groups in parameters
such as pain, vomiting, diarrhea, bloating, headache,
lethargy, and overall well-being, in response to gluten
(Daveson et al. 2011).
The potential for nematode infection to induce pathology
and increase susceptibility to secondary infections, as well
as the lack of long-term studies regarding these therapies,
must be considered when evaluating nematode therapy.
Likewise, the potential psychological effects of live worm
treatment in patients living in a developed culture where
hygiene may be correlated with status has to our knowledge
never been studied. For these reasons, it would be
beneficial to develop treatments that utilize nematode
immune modulation while avoiding the induction of live
nematode infections. One potential method of bypassing
live worm infection, while still obtaining the positive
effects of nematode immune modulation, is to uncover the
specific compounds produced by these parasites and reveal
the manner in which they act to downregulate inflammation
in the gut. As reasoned above, ES products from nematodes
and other helminths are promising candidates for the
development of anti-inflammatory drugs.
To date, there are limited examples of studies examining
nematode-derived immune-modulating components in coli-
tis models. One component is a filarial nematode-derived
cystatin that we previously reported to have ameliorative
effects in a DSS model when administered intraperitoneally
(Schonemeyer et al. 2001). Cystatins are ubiquitous
cysteine protease inhibitors involved in numerous processes
from catabolism to regulation of immune activation.
However, it appears that parasitic nematode cystatins may
have evolved a secondary role and are also capable of
regulating the host immune system. Since the observation
that Acanthocheilonema viteae cystatin is able to inhibit T
cell proliferation (Hartmann et al. 1997), several other
filarial cystatins, both native (Pfaff et al. 2002) and
recombinant (Schierack et al. 2003; Schonemeyer et al.
2001), have been reported to suppress T cell responses.
Reduced antigen presentation and expression of co-
stimulatory molecules by APCs has been observed when
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cells were exposed to filarial nematode cystatin (Manoury
et al. 2001; Murray et al. 2005; Schonemeyer et al. 2001).
Macrophages exposed to filarial cystatins were shown to
increase the production of anti-inflammatory IL-10, as
opposed to the increased IL-12 produced by macrophages
exposed to Caenorhabditis elegans cystatins, supporting
the theory of converging evolutionary development of
cystatins in parasitic nematodes for establishment of
chronic infection in the host (Schierack et al. 2003). Our
group recently revealed the mechanism by which IL-10-
producing macrophages are induced by A. viteae cystatin
(Klotz et al. 2011). We found that A. viteae cystatin is taken
up by macrophages and activates the phosphorylation of
mitogen-activated protein kinases (MAPK), resulting in the
expression of IL-10 (Klotz et al. 2011). The regulation of
this pathway involved the control of MAPK phopsphor-
ylation by dual-specificity phosphatases, showing that the
nematode cystatin exploits activation and deactivation
pathways of MAPK to induce macrophages with an IL-
10-expressing phenotype (Klotz et al. 2011). We currently
investigate the use of the nematode cystatin as therapeutic
for IBD in more detail.
Future perspectives for nematodes in IBD therapy
While the research to date on nematode-derived immu-
nomodulatory substances with potential benefits in IBD
treatment is limited, it can be assumed that the overall
anti-inflammatory effect of live worm infections may be
due to more than one ES product or nematode
component. Therefore, future therapies may benefit from
synergistic effects of multiple nematode immunomodu-
latory products. It is also likely that various nematode
components differ in their suppressive efficiency in
individuals with different etiology or form of IBD.
Genetic screening of individual IBD patients for known
IBD-associated polymorphisms would be essential for
developing patient-specific IBD treatment regimens,
nematode derived and otherwise.
In conclusion, while there is strong evidence that
nematode infections can downregulate intestinal inflam-
mation, much more research on the responsible ES
proteins or nematode components and the active
mechanisms involved is required before safe treatment
options can be clinically tested and marketed for routine
use. Additionally, future IBD therapies developed from
nematode products, as well as the currently marketed
IBD therapies, might benefit from patient-specific
genetic counseling to determine individual IBD pheno-
type and subsequent effective treatment regimen. These
patient-specific therapies may involve nematode-derived
treatments synergizing with the standard therapies.
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